• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    2/14/22 6:44:58 AM ET
    $NNOX
    Medical Electronics
    Health Care
    Get the next $NNOX alert in real time by email
    SC 13G/A 1 d270471dsc13ga.htm SCHEDULE 13G AMENDMENT NO. 1 SCHEDULE 13G Amendment No. 1

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Nano-X Imaging Ltd.

    (Name of Issuer)

    Ordinary shares

    (Title of Class of Securities)

    M70700105

    (CUSIP Number)

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. M70700105   13G   Page  2  of 5 pages        

     

      1   

    NAME OF REPORTING PERSON

     

    SK Telecom Co., Ltd.

      2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  ☐        (b)  ☐

     

      3  

    SEC USE ONLY

     

        

      4  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Republic of Korea

    NUMBER OF  

    SHARES  

    BENEFICIALLY  

    OWNED BY  

    EACH  

    REPORTING  

    PERSON  

    WITH  

       5    

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    0

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    0

      9  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0 (1)

    10  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    0.0%

    12  

    TYPE OF REPORTING PERSON

     

    CO

     

    (1)

    Pursuant to a spin-off (the “Spin-off”) of certain of the businesses of SK Telecom Co., Ltd. (“SKT”), which became effective on November 1, 2021, all of SKT’s ownership interest in its wholly-owned subsidiary, SK Telecom TMT Investment Corp. (“SKT TMT”), a Delaware corporation, was transferred to SK square Co., Ltd. (“SK square”), a Korean corporation newly established pursuant to the Spin-off. As a result of the Spin-off, all of SKT’s indirect beneficial interest in Nano-X Imaging Ltd. (the “Issuer”) immediately prior to the Spin-off, which consisted of (a) 2,607,466 ordinary shares and (b) warrants to purchase 2,262,443 ordinary shares that were held directly by SKT TMT, was also transferred to SK square. Following the Spin-off, SKT TMT changed its name to SK Square Americas, Inc.


    CUSIP No. M70700105   13G   Page  3  of 5 pages        

     

    This Amendment No.1 to Schedule 13G amends and restates in its entirety the Schedule 13G of SK Telecom Co., Ltd., a Korean corporation, and SK Telecom TMT Investment Corp., a Delaware Corporation, dated February 11, 2021.

     

    Item 1.

     

      (a)

    Name of Issuer:

    Nano-X Imaging Ltd.

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    Communications Center,

    Neve Ilan, Israel 9085000

     

    Item 2.

     

      (a)

    Name of Person Filing:

    This Amendment No. 1 to Schedule 13G is being filed by SK Telecom Co., Ltd. (“SKT”).

     

      (b)

    Address of Principal Business Office:

    The address of the principal business office of SKT is 65, Eulji-ro, Jung-gu, Seoul, Korea.

     

      (c)

    Citizenship:

    SKT is a corporation incorporated under the laws of the Republic of Korea.

     

     

      (d)

    Title of Class of Securities:

    Ordinary shares

     

      (e)

    CUSIP Number:

    M70700105

     

    Item 3.

    If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

    Not applicable.

     

    Item 4.

    Ownership.

     

      (a)

    Amount Beneficially Owned:

    See Row 9 of cover page.

     

      (b)

    Percent of Class:

    See Row 11 of cover page.

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    sole power to vote or to direct the vote:

    See Row 5 of cover page.


    CUSIP No. M70700105   13G   Page  4  of 5 pages        

     

      (ii)

    shared power to vote or to direct the vote:

    See Row 6 of cover page.

     

      (iii)

    sole power to dispose or to direct the disposition of:

    See Row 7 of cover page.

     

      (iv)

    shared power to dispose or to direct the disposition of:

    See Row 8 of cover page.

     

    Item 5.

    Ownership of 5 Percent or Less of a Class.

    Not applicable.

     

    Item 6.

    Ownership of More than 5 Percent on Behalf of Another Person.

    Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not applicable.

     

    Item 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    Item 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    Item 10.

    Certifications.

    Not applicable.


    CUSIP No. M70700105   13G   Page  5  of 5 pages        

     

    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: February 14, 2022
    SK TELECOM CO., LTD.
    By:  

    /s/ Heejun Chung

    Name:   Heejun Chung
    Title:   Vice President
    Get the next $NNOX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NNOX

    DatePrice TargetRatingAnalyst
    7/7/2026$3.00Buy → Neutral
    Alliance Global Partners
    1/6/2025$23.00Buy
    D. Boral Capital
    9/8/2023$14.50Buy
    Alliance Global Partners
    1/5/2023$21.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $NNOX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Daniel Ran bought $3,650 worth of Ordinary shares (1,000 units at $3.65), increasing direct ownership by 17% to 6,950 units (SEC Form 4)

    4 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    9/5/25 5:41:26 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Alroy Erez sold $1,119 worth of Ordinary Shares (678 units at $1.65), increasing direct ownership by 145% to 17,075 units (SEC Form 4)

    4 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    6/15/26 4:05:24 PM ET
    $NNOX
    Medical Electronics
    Health Care

    New insider Suesskind Dan S claimed ownership of 25,336 units of Ordinary shares (SEC Form 3)

    3 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    4/30/26 2:31:47 PM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form 3 filed by new insider Yahav Attias Gali

    3 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    4/9/26 7:31:56 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nano-X Imaging downgraded by Alliance Global Partners with a new price target

    Alliance Global Partners downgraded Nano-X Imaging from Buy to Neutral and set a new price target of $3.00

    7/7/26 8:44:27 AM ET
    $NNOX
    Medical Electronics
    Health Care

    D. Boral Capital initiated coverage on Nano-X Imaging with a new price target

    D. Boral Capital initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $23.00

    1/6/25 9:02:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Alliance Global Partners initiated coverage on Nano-X Imaging with a new price target

    Alliance Global Partners initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $14.50

    9/8/23 9:14:06 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026

    New SCCT abstracts from Brigham and Women’s Hospital highlight the performance and clinical utility of Nanox.AI’s FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its potential role in supporting guideline-directed preventive care. From incidental finding to clinical action: the AI INFORM randomized trial highlights how AI-detected coronary calcium may help clinicians identify opportunities for preventive lipid-lowering therapy. Nanox.AI Sponsors SCCT Scientific Session, "From Missed Finding to Missed Opportunity: Aortic Valve Calcification on Chest CT," Featuring Ofir Koren, MD, Cedars-Sinai Medical Center, on Sunday, July 12, at 7:30 am PETACH TIKVA, Is

    7/7/26 8:10:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

    PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2026, before market open on Thursday, June 25, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2026 Call Registration The live webcast of the conference call may be accessed

    6/11/26 4:01:00 PM ET
    $NNOX
    Medical Electronics
    Health Care

    Exclusive distribution agreement marks Nanox's entry into the Peruvian market

    Initial deployment is expected to include six Nanox.ARC systems under a capex model PETACH TIKVA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (("Nanox", NASDAQ:NNOX), a leader in innovative medical imaging technology, today announced a distribution agreement with Top Med SAC ("Top Med") to deploy the Nanox.ARC system and related services in Peru. Under the agreement, Nanox appointed Top Med as its exclusive distributor of the Nanox.ARC system and Nanox platform in Peru, subject to commercial milestones and regulatory requirements. The agreement is structured as a capex model and includes an expected initial deployment of six Nanox.ARC systems, subject to receipt of t

    6/2/26 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    SEC Filings

    View All

    SEC Form 6-K filed by NANO-X IMAGING LTD

    6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

    6/25/26 8:05:01 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by NANO-X IMAGING LTD

    SCHEDULE 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    5/15/26 6:11:44 AM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form 20-F filed by NANO-X IMAGING LTD

    20-F - Nano-X Imaging Ltd. (0001795251) (Filer)

    4/30/26 4:03:41 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Leadership Updates

    Live Leadership Updates

    View All

    Nanox Announces Appointment of Medical Executive Moshe Shtengel as Chief Business Officer

    NEVE ILAN, Israel, May 03, 2021 (GLOBE NEWSWIRE) -- NANOX IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, announced today the appointment of Moshe Shtengel as Chief Business Officer, effective May 2, 2021. Mr. Shtengel joins Nanox from Tuttnauer, a global manufacturer of sterilizers and infection control systems for medical institutions, where he served as Vice President of Global Sales, Marketing and Products. "Moshe is an extremely seasoned sales and business development executive with a proven track record of success and leadership in the medical field," stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. "As we

    5/3/21 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Financials

    Live finance-specific insights

    View All

    Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

    PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2026, before market open on Thursday, June 25, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2026 Call Registration The live webcast of the conference call may be accessed

    6/11/26 4:01:00 PM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

    Advanced commercialization in the US, signing multiple new customer and distribution agreements for Nanox.ARC and accelerated activities around Nanox.AI Management to host conference call and webcast Monday, April 20, 2026 at 8:30 AM ET Appointed new CFO effective August 1, 2026 PETAH TIKVA, Israel, April 20, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2025, and provided a business update. Recent Highlights: Generated $3.7 million in revenue in the fourth quarter of 2025, compared to $3.0 million in the fourth quarter o

    4/20/26 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026

    PETACH TIKVA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended December 31, 2025, before market open on Monday, April 20, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q4 2025 Call The live webcast of the conference call may be accessed by using t

    4/6/26 4:05:00 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    3/7/24 12:29:51 PM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form SC 13G filed by NANO-X IMAGING LTD

    SC 13G - Nano-X Imaging Ltd. (0001795251) (Subject)

    2/6/24 9:36:34 AM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    2/14/23 4:15:16 PM ET
    $NNOX
    Medical Electronics
    Health Care